|
Volumn 13, Issue 3, 2001, Pages 569-575
|
The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus
a a |
Author keywords
Limbic neuroprotection; Nonsteroidal anti inflammatory drugs; Seizure; TUNEL staining
|
Indexed keywords
CELL MARKER;
CYCLOOXYGENASE 2 INHIBITOR;
KAINIC ACID;
ROFECOXIB;
AMYGDALOID NUCLEUS;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
CELL DEATH;
CELL LOSS;
CELL VIABILITY;
COMPLEX PARTIAL SEIZURE;
ENZYME ACTIVITY;
HIPPOCAMPUS;
NEUROTOXICITY;
NICK END LABELING;
NONHUMAN;
PRIORITY JOURNAL;
PYRAMIDAL NERVE CELL;
PYRIFORM CORTEX;
RAT;
ANIMALS;
CELL DEATH;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
EPILEPSY;
EXCITATORY AMINO ACID AGONISTS;
GENE EXPRESSION REGULATION, ENZYMOLOGIC;
HIPPOCAMPUS;
IN SITU NICK-END LABELING;
ISOENZYMES;
KAINIC ACID;
LACTONES;
MALE;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PYRAMIDAL CELLS;
RATS;
RATS, SPRAGUE-DAWLEY;
RNA, MESSENGER;
SEIZURES;
SULFONES;
|
EID: 0035133996
PISSN: 0953816X
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1460-9568.2001.01420.x Document Type: Article |
Times cited : (147)
|
References (39)
|